Combining Carbapenems and Amikacin Against KPC-Producing Klebsiella Pneumoniae
Author Information
Author(s): Jennifer Le, Barbara McKee, Warunee Srisupha-Olarn, David S. Burgess
Primary Institution: University of California, San Diego
Hypothesis
Can the combination of carbapenems and amikacin effectively treat KPC-producing Klebsiella pneumoniae?
Conclusion
The combination of meropenem or imipenem with amikacin showed synergistic activity against KPC-3-producing Klebsiella pneumoniae isolates.
Supporting Evidence
- All isolates were resistant to carbapenems and amikacin.
- Synergy was demonstrated for meropenem and imipenem in combination with amikacin.
- None of the antibiotics alone achieved significant bactericidal activity.
Takeaway
Using two antibiotics together can help fight off superbugs that are hard to treat. In this study, mixing certain antibiotics worked better against a tough germ.
Methodology
Time-kill studies were performed to evaluate the effectiveness of carbapenems and amikacin against clinical isolates of Klebsiella pneumoniae.
Limitations
The study was limited to in vitro conditions and may not directly translate to clinical outcomes.
Participant Demographics
Four non-duplicate clinical isolates of Klebsiella pneumoniae were used.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website